Skip to main content

Diagnosis of Alzheimer Disease Progression Stage from Cross Sectional Cognitive Data by Deep Neural Network

  • Conference paper
  • First Online:
Progress in Artificial Intelligence and Pattern Recognition (IWAIPR 2023)

Abstract

The use of deep learning in diagnostic and modeling the progression of neurodegenerative diseases has had a significant boom in the last years. The model complexity, due to the large quantity and diversity of data necessary for their training, do not make them affordable in conditions where obtaining clinical data and magnetic resonance imaging are expensive and complex. However, under these conditions it is feasible using scores from cognitive functions. These techniques are cheap and do not require the use of sophisticated equipment. In this work we propose a deep learning based model for classification of cognitive vectors collected from each patient taking into account the labels corresponding to the disease stage (normal, mild cognitive impairment, and diseased). Experiments on ADNI cohorts shown that our proposal maintained an average accuracy of 0.968 with a standard deviation of 0.01, which is higher than the obtained by the compared methods. The experiments demonstrated the feasibility of the proposed model.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Notes

  1. 1.

    Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_aply/ADNI_Acknowledgement_List.pdf.

References

  1. Khachaturian, Z.S.: Diagnosis of Alzheimer’s disease. Arch. Neurol. 42(11), 1097–1105 (1985). Nov.

    Article  Google Scholar 

  2. Almaguer-Melian, W., Mercerón-Martínez, D., Bergado-Rosado, J.: A unique erythropoietin dosage induces the recovery of long-term synaptic potentiation in fimbria-fornix lesioned rats. Brain Research 1799, 148178 (2023). https://doi.org/10.1016/j.brainres.2022.148178

  3. Wang, X., Qi, J., Yang, Y., Yang, P.: A Survey of Disease Progression Modeling Techniques for Alzheimer's Diseases. In: 2019 IEEE 17th International Conference on Industrial Informatics (INDIN), pp. 1237–1242 (2019). https://doi.org/10.1109/INDIN41052.2019.8972091

  4. Folstein, M.F., Folstein, S.E., McHugh, P.R.: Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr Res. 12(3), 189–98 (1975)

    Google Scholar 

  5. Schmidt, M.: Rey Auditory Verbal Learning Test: A Handbook RAVLT (1996)

    Google Scholar 

  6. Chu, L.W., et al.: “The reliability and validity of the Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) among the elderly” Chinese in Hong Kong. Ann Acad. Med. Singapore 29(4), 474–85 (Jul. 2000)

    Google Scholar 

  7. Frisoni, G.B., Fox, N.C., Jack, C., Scheltens, M., Thompson,P.P.: The clinical use of structural MRI in Alzheimer disease. Nature Reviews Neurology (2010)

    Google Scholar 

  8. Baskaran, K.R., Sanjay, V.: Deep learning based early Diagnosis of Alzheimer’s disease using Semi Supervised GAN. Annals of the Romanian Society for Cell Biology, 7391–7400 (2021)

    Google Scholar 

  9. Wan, J., et al.: Sparse Bayesian multi-task learning for predicting cognitive outcomes from neuroimaging measures in Alzheimer’s disease. IEEE Conference on Computer Vision and Pattern Recognition 2012, 940–947 (2012). https://doi.org/10.1109/CVPR.2012.6247769

    Article  Google Scholar 

  10. Wan, J., et al.: Identifying the neuroanatomical basis of cognitive impairment in Alzheimer’s disease by correlation- and nonlinearity-aware sparse bayesian learning. IEEE Trans. Med. Imaging 33(7), 1475–1487 (2014). https://doi.org/10.1109/TMI.2014.2314712. July

    Article  Google Scholar 

  11. Al-Shourky, S., Rassem, T.H., Makbol, N.M.: “Alzheimer’s Diseases Detection by Using Deep Learning Algorithms”: A Mini-Review. IEEE Access 8 (2020)

    Google Scholar 

  12. Jain, R., Aggarwal, A., Kumar, V.: Chapter 1 - A review of deep learning-based disease detection in Alzheimer's patients. In: Jude, H.D. (ed.) Handbook of Decision Support Systems for Neurological Disorders, pp. 1–19. Academic Press (2021). https://doi.org/10.1016/B978-0-12-822271-3.00004-9

  13. Ghada, M., Fadhl, A., Algaphari, G.H.: Machine learning and deep learning-based approaches on various biomarkers for Alzheimer’s disease early detection: A review. IJSECS 7(2), 26–43 (2021). https://doi.org/10.15282/ijsecs.7.2.2021.4.0087

  14. Monfared, T., Byrnes, A.A., White, M.J., et al.: Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurol Ther 11, 553–569 (2022). https://doi.org/10.1007/s40120-022-00338-8

  15. Peng, H., Long, F., Ding, C.: Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans. Pattern Anal. Mach. Intell. 27, 1226–1238 (2005)

    Article  Google Scholar 

  16. Lichtenberg, P.A., (ed.): Handbook of Assessment in Clinical Gerontology, 2nd Edition, pp. 179–210. Academic Press (2010). ISBN 9780123749611, https://doi.org/10.1016/B978-0-12-374961-1.10007-7

  17. Gelbowitz, A.: Decision Trees and Random Forests Guide: An Overview of Decision Trees and Random Forests: Machine Learning Design Patterns. Independently Published (2021)

    Google Scholar 

  18. Xanthopoulos, P., Pardalos, P.M., Trafalis, T.B.: Linear discriminant analysis. In: Robust Data Mining. SpringerBriefs in Optimization. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9878-1_4

  19. Ronneberger, O., Fischer, P., Brox, T. U-net: convolutional networks for biomedical image segmentation. In: Navab, N., Hornegger, J., Wells, W., Frangi, A. (eds.) Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. MICCAI 2015. Lecture Notes in Computer Science(), vol 9351. Springer, Cham (2015). https://doi.org/10.1007/978-3-319-24574-4_28

  20. He, K., Zhang, X., Ren, S., Sun, J.: Deep Residual Learning for Image Recognition, 770–778 (2016). https://doi.org/10.1109/CVPR.2016.90

Download references

Acknowledgement

Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12–2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.

This work was also founded by the Cuban Center for Neurosciences through project PN305LH013-015. Development of disease progression models for brain dysfunctions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eduardo Garea-Llano .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Garea-Llano, E., León Pino, S., Martinez-Montes, E. (2024). Diagnosis of Alzheimer Disease Progression Stage from Cross Sectional Cognitive Data by Deep Neural Network. In: Hernández Heredia, Y., Milián Núñez, V., Ruiz Shulcloper, J. (eds) Progress in Artificial Intelligence and Pattern Recognition. IWAIPR 2023. Lecture Notes in Computer Science, vol 14335. Springer, Cham. https://doi.org/10.1007/978-3-031-49552-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-49552-6_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-49551-9

  • Online ISBN: 978-3-031-49552-6

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics